The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
Open accessAbstract
Fungal bloodstream infections are associated with significant patient mortality and health care costs. Nevertheless, the relationship between a delay of the initial empiric antifungal treatment until blood culture results are known and the clinical outcome is not well established. A retrospective cohort analysis with automated patient medical records and the pharmacy database at Barnes-Jewish Hospital was conducted. One hundred fifty-seven patients with a Candida bloodstream infection were identified over a 4-year period (January 2001 through December 2004). Fifty (31.8%) patients died during hospitalization. One hundred thirty-four patients had empiric antifungal treatment begun after the results of fungal cultures were known. From the time that the first blood sample for culture that was positive was drawn, 9 (5.7%) patients received antifungal treatment within 12 h, 10 (6.4%) patients received antifungal treatment between 12 and 24 h, 86 (54.8%) patients received antifungal treatment between 24 and 48 h, and 52 (33.1%) patients received antifungal treatment after 48 h. Multiple logistic regression analysis identified Acute Physiology and Chronic Health Evaluation II scores (one-point increments) (adjusted odds ratio [AOR], 1.24; 95% confidence interval [CI], 1.18 to 1.31; P < 0.001), prior antibiotic treatment (AOR, 4.05; 95% CI, 2.14 to 7.65; P = 0.028), and administration of antifungal treatment 12 h after having the first positive blood sample for culture (AOR, 2.09; 95% CI, 1.53 to 2.84; P = 0.018) as independent determinants of hospital mortality. Administration of empiric antifungal treatment 12 h after a positive blood sample for culture is drawn is common among patients with Candida bloodstream infections and is associated with greater hospital mortality. Delayed treatment of Candida bloodstream infections could be minimized by the development of more rapid diagnostic techniques for the identification of Candida bloodstream infections. Alternatively, increased use of empiric antifungal treatment in selected patients at high risk for fungal bloodstream infection could also reduce delays in treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Finally, in a study of 10,811 patients treated in four Utah hospitals, each hour delay in time from ED arrival to administration of antimicrobials was associated with 1.16 increased odds of in-hospital and 1.10 increased odds of 1-year mortality (1.13 in patients with hypotension vs 1.09 in patients without hypotension) (111).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [111]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Observational studies do, however, suggest that mortality may increase after intervals exceeding 3-5 hours from hospital arrival and/or sepsis recognition (98,111,119,120).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [111]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Attributable mortality from IC remains high and increases with delays in treatment.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [136]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Blood cultures take an average of 2–3 days to grow Candida, or longer depending on the species.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [136]
Experimental — accuracy not yet measuredIn the citing paper
“Some observational studies suggested that prompt initiation of appropriate empiric antifungal therapy may be associated with a reduction in mortality, however these studies do not prove a causal relationship between antifungal therapy and outcome, nor do they clarify the role of timing of treatment, and some other studies have failed to show this association [167, 171–173].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [173]
In the citing paper
“As mentioned previously, diagnosis of invasive candidiasis and candidemia remains a great challenge, since symptoms and signs are usually non-specific, microbiological cultures are difficult to analyze, and histological specimens require invasive procedures [29,30,46].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [30]
In the citing paper
“Another single-center retrospective cohort of 157 consecutive patients with a Candida BSI showed a trend toward improved survival when appropriate antifungal therapy was administered within 12 hours of blood culture collection (mortality 11.1% vs 33.1%; P 5 .169).45”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [45]
In the citing paper
“In multivariate analysis the odds of death was 2-fold higher if adequate therapy was delayed more than 12 hours (P 5 .018).”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [45]
In the citing paper
“Invasive candidiasis occurs frequently in hospitalized patients, and is associated with high mortality rates due to delays in recognition and initiation of appropriate antifungals.”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [70]
In the citing paper
“There is extensive clinical evidence that delayed initiation of appropriate antifungal treatment is associated with increased mortality in patients with invasive candidiasis [70,71,72].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [70]
In the citing paper
“Mortality rates are estimated to be as high as 45% [16], probably due to inefficient diagnostic methods and inappropriate initial antifungal therapies [17].”
From Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents (2013) · cites this paper as [17]
In the citing paper
“The Clinical and Laboratory Standards Institute (CLSI) Subcommittee for Antifungal Testing has developed standardized broth microdilution (BMD) (169) and disk diffusion (170) methods for in vitro susceptibility testing of Candida spp.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [170]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
APACHE II: a severity of disease classification system.
Knaus, W. A., Draper, E. S., Wagner, D. P., & Zimmerman, J. E. (1985) · PubMed · Cited by 6,034
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Inadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Self-citationIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
Self-citationComparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Weinstein, M. P., Towns, M., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Reller, L. B. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,225
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
The Risk of Determining Risk with Multivariable Models
Concato, J., Feinstein, A. R., & Holford, T. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00009 · Cited by 1,119
Cited by
Sorted by citations
Items 701–800 of 1,000
Clinical Aspects of Invasive Candidiasis in Critically Ill Patients
Pennisi, M. A., & Antonelli, M. M. (2009) · Drugs · doi:10.2165/11315590-000000000-00000 · Cited by 15
Sheikhbahaei, S., Mohammadi, A., Sherkat, R., Naeini, A. E., Yaran, M., & Najafi, S. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666190211163245 · Cited by 14
Rapid diagnosis of invasive candidiasis: ready for prime-time?
Clancy, C. J., & Nguyen, M. H. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000594 · Cited by 15
Candidaemia in Central Slovenia: A 12‐year retrospective survey
Matos, T., Zupanc, T. L., Škofljanec, A., Jazbec, A., Matos, E., Vodičar, P. M., Germ, J., Ciglar, T., Tomazin, R., Kofol, R., et al. (2021) · Mycoses · doi:10.1111/myc.13278 · Cited by 15
Clinical and Microbiological Characteristics of Candidemia Cases in Saudi Arabia
Alkhalifa, W., Alhawaj, H., Alamri, A. M., Alturki, F., Alshahrani, M. S. S., & Alnimr, A. M. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s411865 · Cited by 15
Design and use of Candida scores at the intensive care unit
Kratzer, C., Graninger, W., Lassnigg, A. M., & Presterl, E. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01953.x · Cited by 15
Bias, T. E., Vincent, W. R., Trustman, N., Berkowitz, L. B., & Venugopalan, V. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160096 · Cited by 14
Baronia, A. K., Sharma, P., Yadav, R., Marak, R. S. K., & Singh, R. K. (2017) · Indian Journal of Critical Care Medicine · doi:10.4103/ijccm.ijccm_33_17 · Cited by 15
Opportunistic and Systemic Fungi
Kosmidis, C., & Denning, D. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00189-1 · Cited by 16
Zeitler, K. E., & Narayanan, N. (2019) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-019-00190-9 · Cited by 14
Sakka, S. G., Kochem, A.-J., Disqué, C., & Wellinghausen, N. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181b79904 · Cited by 14
Bone Suppression Increases the Visibility of Invasive Pulmonary Aspergillosis in Chest Radiographs
Schalekamp, S., van Ginneken, B., van den Berk, I. A. H., Hartmann, I. J. C., Snoeren, M. M., Odink, A. E., van Lankeren, W., Pegge, S., Schijf, L. J., Karssemeijer, N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108551 · Cited by 14
Chen, H., Suda, K. J., Turpin, R. S., Pai, M. P., Bearden, D. T., & Garey, K. W. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x182130 · Cited by 14
Treatment Principles for Candida and CryptococcusPreprint
Whitney, L., & Bicanic, T. A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024158 · Cited by 15
Kapralos, I., Mainas, E., Neroutsos, E., Apostolidi, S., Siopi, M., Apostolopoulou, O., Dimοpoulos, G., Sambatakou, H., Valsami, G. N., Meletiadis, J., et al. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13353 · Cited by 13
Zhao, Y.-S., Lai, Q., Tang, H., Luo, R.-J., He, Z., Huang, W., Wang, L., Zhang, Z., Lin, S., Qin, W., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1386161 · Cited by 13
Grau, S., Salavert, M., Laderas, J. C. P., Vargas, M., Barrueta, J. A., & Mir, N. (2013) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2013.05.004 · Cited by 13
Small Molecules in Treatment of Sepsis
Hu, Y. L., Xie, G. H., Chen, Q. X., & Fang, X. M. (2011) · Current Drug Targets · doi:10.2174/138945011794182737 · Cited by 13
The Role of In Vitro Susceptibility Testing in the Management of Candida and Aspergillus
Ostrosky-Zeichner, L. L., & Andes, D. R. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix239 · Cited by 13
Allaire, M., Cadranel, J., Nguyen, T. T. N., Garioud, A., Zougmoré, H., Heng, R., Pérignon, C., Ollivier‐Hourmand, I., & Dao, T. (2019) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.10.003 · Cited by 14
Karthaus, M., Rüping, M. J. G. T., Cornely, O. A., Steinbach, A., Groll, A. H., Lass‐Flörl, C., Ostermann, H., Ruhnke, M., & Vehreschild, J. J. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01988.x · Cited by 13
Histopathological Study of Candidal Infection in the Central Nervous System
Nakayama, H., Shibuya, K., Kimura, M., Ueda, M., & Iwabuchi, S. (2010) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.51.31 · Cited by 13
Predictors of Candida spp. as causative agents of catheter-related bloodstream infections
Nagao, M., Hotta, G., Yamamoto, M., Matsumura, Y., Ito, Y., Takakura, S., & Ichiyama, S. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.08.003 · Cited by 13
Inhibitory effect of Murraya koenigii against Candida albicans virulence and biofilm development
Muthamil, S., & Pandian, S. K. (2016) · Biologia · doi:10.1515/biolog-2016-0044 · Cited by 13
Gökbolat, E., Öz, Y., & Metintaş, S. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000434 · Cited by 13
Azoulay, É., Timsit, J., Lautrette, A., Legriel, S., Max, A., Ruckly, S., Misset, B., Cohen, Y., & Wolff, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177093 · Cited by 13
Walker, B. S., Schmidt, R. L., Tantravahi, S. K., Kim, K., & Hanson, K. E. (2019) · Transplant Infectious Disease · doi:10.1111/tid.13148 · Cited by 13
Zatta, M., Bella, S. D., Giacobbe, D. R., Puente, F. D., Merelli, M., Azzini, A. M., Brugnaro, P., Vedovelli, C., Cattelan, A. M., Busetti, M., et al. (2020) · Gerontology · doi:10.1159/000510638 · Cited by 13
Management of Severe Sepsis in the Surgical Patient
Sihler, K. C., & Nathens, A. B. (2006) · Surgical Clinics of North America · doi:10.1016/j.suc.2006.09.005 · Cited by 13
Kumar, S., Nambisan, B., Mohandas, C., & Sundaresan, A. (2013) · Folia Microbiologica · doi:10.1007/s12223-013-0234-x · Cited by 13
Use of T2MR in Invasive Candidiasis with and Without Candidemia
Zacharioudakis, I. M., Zervou, F. N., & Mylonakis, E. E. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0079 · Cited by 13
Gómez, J., García‐Vázquez, E., Espinosa, C., Ruiz, J., Canteras, M., Hernández‐Torres, A., Baños, V., Herrero, J. A., & Valdés, M. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2009.06.066 · Cited by 13
Recent Challenges in Diagnosis and Treatment of Invasive Candidiasis in Neonates
Baltogianni, M. S., Giapros, V. I., & Dermitzaki, N. (2024) · Children · doi:10.3390/children11101207 · Cited by 13
Xafranski, H., Melo, A. S. D. A., Machado, A. M. O., Briones, M. R. S., & Colombo, A. L. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-467 · Cited by 12
Garnacho‐Montero, J., Díaz‐Martín, A., & Cayuela, A. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70015-3 · Cited by 12
Clancy, C. J., Shields, R. K., & Nguyen, M. H. (2016) · Journal of Fungi · doi:10.3390/jof2010010 · Cited by 13
Ghanem‐Zoubi, N., Zorbavel, D., Khoury, J., Geffen, Y., Qasum, M., Predescu, S., & Paul, M. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3389-1 · Cited by 12
Evaluation of the updated “Candida score” with Sepsis 3.0 criteria in critically ill patients
Li, D., Zhang, J., Han, W., Bai, G., Cheng, W., & Cui, N. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-995 · Cited by 12
„Tarragona-Strategie“ – adäquate Antibiotikatherapie auf der Intensivstation
Engelmann, L., & Schmitt, D. (2014) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-013-0310-7 · Cited by 12
Lee, W., Liew, Y., Chlebicki, M. P., Ong, S. G. K., Lee, P., & Kwa, A. L. (2014) · Critical Care Research and Practice · doi:10.1155/2014/479413 · Cited by 12
Candidemia in the critically ill: initial therapy and outcome in mechanically ventilated patients
Ferrada, M. A., Quartin, A. A., Kett, D. H., & Morris, M. I. (2013) · BMC Anesthesiology · doi:10.1186/1471-2253-13-37 · Cited by 12
Forstner, C., Lassnigg, A. M., Tobudic, S., Schiferer, A., Fischer, H., Graninger, W., Steinlechner, B., Frantal, S., & Presterl, E. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.02.003 · Cited by 12
Anidulafungin in the treatment of patients with invasive candidiasis
Kett, D. H., & Cubillos, G. F. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70008-6 · Cited by 12
Relloso, M. S., Nievas, J., Taie, S. F., Farquharson, V., Mujica, M. T., Romano, V., Zárate, M. S., & Smayevsky, J. (2015) · Revista Argentina de Microbiología · doi:10.1016/j.ram.2015.02.004 · Cited by 12
Ahmadi, A., Ardehali, S. H., Beigmohammadi, M. T., Hajiabdolbaghi, M., Hashemian, S. M. R., Kouchek, M., Majidpour, A., Mokhtari, M., Moghaddam, O. M., Najafi, A., et al. (2014) · JRSM Open · doi:10.1177/2042533313517689 · Cited by 12
Öz, Y., & Gökbolat, E. (2017) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22297 · Cited by 12
Clinical predictors of candidemia in medical non-neutropenic, non-ICU patients. The CaMed score
Ruiz‐Ruigómez, M., Dueñas, C., Hernandez, C., García, D. V., Coronado-Álvarez, N. M., Portillo-Tuñón, V., Cardozo, C., Muñoz‐Medina, L., Cabo-Magadán, R., Luna, J. D. D., et al. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13275 · Cited by 12
Azim, A., Ahmed, A., Baronia, A. K., Marak, R. S. K., & Muzzafar, N. (2017) · EMJ Nephrology · doi:10.33590/emjnephrol/10310735 · Cited by 13
Baronia, A. K., & Marak, R. S. K. (2015) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.158273 · Cited by 12
A survey on infection management practices in Italian ICUs
Bassetti, M., Gaudio, R. D., Mazzei, T., Morace, G., Petrosillo, N., Viale, P., Bello, G., Face, S. L., & Antonelli, M. M. (2012) · Critical Care · doi:10.1186/cc11866 · Cited by 12
Micek, S. T., Arnold, H. M., Juang, P., Hampton, N. B., McKenzie, M., Scolarici, M. J., & Kollef, M. H. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.06.028 · Cited by 12
Self-citationCandida: What Should Clinicians and Scientists Be Talking About?
Spellberg, B. J., Marr, K. A., & Filler, S. G. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch1 · Cited by 13
Bennett, J. E. (2008) · Clinical Infectious Diseases · doi:10.1086/528692 · Cited by 12
Management of Intra-Abdominal Candidiasis in Intensive Care Setting: A Narrative Review
Pais, M. M., Zaragoza, R., Martín‐Loeches, I., Gómez-Bertomeu, F., & Rodríguez, A. H. (2025) · Journal of Fungi · doi:10.3390/jof11050362 · Cited by 11
Deep learning application to hyphae and spores identification in fungal fluorescence images
Ren, R., Tan, W., Chen, S., Xu, X., Zhang, D., Chen, P., & Zhu, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-11228-y · Cited by 11
Fungal Infection in Burn Patents
Tu, Y., Lineaweaver, W. C., Breland, A., & Zhang, F. (2021) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000002865 · Cited by 11
Jan, H.-E., Lo, C.-L., Lee, J., Li, M.-C., Lin, W.-L., Ko, W., & Lee, N. (2023) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2023.08.014 · Cited by 11
Craver, C., Tarallo, M., Roberts, C. S., Blanchette, C. M., & Ernst, F. R. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.01.001 · Cited by 11
Bailly, S., Garnaud, C., Cornet, M., Pavèse, P., Hamidfar-Roy, R., Foroni, L., Boisset, S., Timsit, J., & Maubon, D. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2633-9 · Cited by 11
Li, F., Yu, X., Ye, L., Zhou, G., Wang, L., & Luo, Y. (2019) · Medical Mycology · doi:10.1093/mmy/myy158 · Cited by 10
Diagnosis and Treatment of Invasive Fungal Infections Focus on Liposomal Amphotericin B
de Lacerda, J. F., & Meneses-Oliveira, C. (2013) · Clinical Drug Investigation · doi:10.1007/s40261-012-0023-3 · Cited by 11
Lewis, R. E. (2011) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181ff7e10 · Cited by 11
Wennerås, C., Hagberg, L., Andersson, R., Hynsjö, L., Lindahl, A. H., Okrój, M., Blom, A. M., Johansson, P., Andréasson, B., Gottfries, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092319 · Cited by 10
Infección fúngica invasiva en los pacientes ingresados en las áreas de críticos
Garnacho‐Montero, J., Díaz‐Martín, A., de Piappon, M. R. P., & García-Cabrera, E. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2012.02.011 · Cited by 16
Farina, C., Manso, E., Andreoni, S., Conte, M., Fazii, P., Lombardi, G., Sanna, S., & Russello, G. (2011) · PubMed · Cited by 11
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis
Lagunes, L., Borgatta, B., Martín-Gómez, M. T., Rey-Perez, A., Antonelli, M. M., Righi, E., Merelli, M., Brugnaro, P., Dimopoulos, G., Garnacho‐Montero, J., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.06.005 · Cited by 11
van der Geest, P. J., Hunfeld, N., Ladage, S. E., & Groeneveld, A. B. J. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1825-3 · Cited by 12
Cui, N., Wang, H., Qiu, H., Li, R., & Liu, D. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.02.019 · Cited by 13
Bordallo-Cardona, M. Á., Marcos-Zambrano, L. J., Sánchez‐Carrillo, C., Bouza, E., Muñóz, P., Escribano, P., & Guinea, J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00162-18 · Cited by 11
Hasani, A., Faezi, N. A., Rezaee, M. A., Sheykhsaran, E., Darabi, N., & Leylabadlo, H. E. (2019) · International Journal of Enteric Pathogens · doi:10.15171/ijep.2019.12 · Cited by 11
Existing and emerging therapies for the treatment of invasive candidiasis and candidemia
Bels, D. D., Maillart, E., Françoise Van Bambeke, A., Redant, S., & Honoré, P. M. (2022) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2022.2142207 · Cited by 12
Importance of pulmonary imaging diagnostics in the management of febrile neutropenic patients
Heußel, C. P. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01982.x · Cited by 11
Clinical Aspects of Invasive Candidiasis in the Surgical Patient
Sganga, G. (2009) · Drugs · doi:10.2165/11315600-000000000-00000 · Cited by 11
Salomão, R., Diament, D., Rigato, O., Gomes, B., Silva, E., Carvalho, N. B., & Machado, F. R. (2011) · PubMed · Cited by 11
An automated dispensing system for improving medication timing in the emergency department
Ward, M. J., Boyd, J. S., Harger, N. J., Deledda, J. M., Smith, C. L., Walker, S. M., Hice, J. D., Hart, K. W., Lindsell, C. J., & Wright, S. (2012) · World Journal of Emergency Medicine · doi:10.5847/wjem.j.issn.1920-8642.2012.02.004 · Cited by 11
Uppuluri, P., Khan, A. A., & Edwards, J. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_2 · Cited by 14
Cortegiani, A., Russotto, V., Raineri, S. M., Gregoretti, C., Rosa, F. G. D., & Giarratano, A. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0288-3 · Cited by 11
Systemic Candidiasis: Candidemia and Deep-Organ Infections
Clancy, C. J., & Nguyen, M. H. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch27 · Cited by 12
Are prophylactic antifungals in highly colonized patients safe and effective?
Bassetti, M., León, C., & Timsit, J. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3888-9 · Cited by 11
The small molecule CBR-5884 inhibits the Candida albicans phosphatidylserine synthase
Zhou, Y., Phelps, G. A., Mangrum, M. M., McLeish, J., Phillips, E. K., Lou, J., Ancajas, C. F., Rybak, J. M., Oelkers, P. M., Lee, R. E., Jr., et al. (2024) · mBio · doi:10.1128/mbio.00633-24 · Cited by 10
Role of source control in critically ill candidemic patients: a multicenter retrospective study
Marangos, M. N., Ιωάννου, Π., Senn, L., Spiliopoulou, A., Tzalis, S., Kolonitsiou, F., Valta, M., Kokkini, S., Pagani, J., Stafylaki, D., et al. (2024) · Infection · doi:10.1007/s15010-024-02222-z · Cited by 12
Meng, Q., Chen, B., Xu, Y., Zhang, Q., Ding, R., Gao, Q., Du, K., Ma, Z., Jin, Z., Gao, S., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309748 · Cited by 12
Farina, C., Russello, G., Andreoni, S., Bonetti, C., Conte, M., Fazi, P., Lombardi, G., Luzzaro, F., Manso, E., Marone, P., et al. (2012) · Medical Mycology · doi:10.3109/13693786.2011.648216 · Cited by 10
Husni, R., Chrabieh, R., Dib, R. W., Vázquez, J. A., Guimarães, T., Fernandez, A. R., Khoury, R., Asmar, L., Khazen, G., Samaha, N. L., et al. (2021) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2021.031 · Cited by 11
Thangamathesvaran, L., Canner, J. K., Scott, A. W., Woreta, F. A., & Breazzano, M. P. (2022) · Eye · doi:10.1038/s41433-022-02080-9 · Cited by 10
Ahn, H., Lee, R., Cho, S., & Lee, D. (2022) · Blood Research · doi:10.5045/br.2022.2022036 · Cited by 12
d’Enfert, C., & Bougnoux, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00139-2 · Cited by 15
The Potential for PCR Based Testing to Improve Diagnosis and Treatment of Sepsis
Lyle, N. H., & Boyd, J. H. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0350-4 · Cited by 10
Antifungal Stewardship: an Emerging Practice in Antimicrobial Stewardship
Andruszko, B., & Ashley, E. D. (2016) · Current Clinical Microbiology Reports · doi:10.1007/s40588-016-0039-1 · Cited by 11
Kianipour, S., Ardestani, M. E., & Dehghan, P. (2018) · Advanced Biomedical Research · doi:10.4103/abr.abr_138_17 · Cited by 10
Falces‐Romero, I., Cendejas‐Bueno, E., Laplaza-González, M., Escosa‐García, L., Schüffelmann, C., Calderón-Llopis, B., Pemán, J., de la Oliva, P., & García‐Rodríguez, J. (2018) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2018.05.006 · Cited by 10
Management of patients with septic shock due toCandidainfection
Bassetti, M., Vena, A., & Russo, A. (2018) · Hospital Practice · doi:10.1080/21548331.2018.1518104 · Cited by 11
Hogan, M., Bridgeman, M. B., Min, G. H., Dixit, D., Bridgeman, P. J., & Narayanan, N. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s174570 · Cited by 10
Guenter, S., Gorkiewicz, G., Halwachs, B., Kashofer, K., Thueringer, A., Wurm, P., Zollner‐Schwetz, I., Valentin, T., Prattes, J., Wunsch, S., et al. (2020) · Journal of Fungi · doi:10.3390/jof6020043 · Cited by 10
Hautala, N. M., Köykkä, H., Siiskonen, M., Saari, J., Kauranen, J., & Hautala, T. (2021) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2021-000837 · Cited by 10
Fun with fungi: a comprehensive review of common fungal organisms encountered in cytology
Torous, V. F., & Branda, J. A. (2022) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2022.11.004 · Cited by 10
Invasive Fungal Infections and Approaches to Their Diagnosis
Pfaller, M. A. (2015) · Methods in microbiology · doi:10.1016/bs.mim.2015.05.002 · Cited by 11
Wang, H., Wu, D., Han, H., Yue, J.-F., Zhang, F., Shan, T., Guo, H., & Yin, M. (2014) · Saudi Medical Journal · doi:10.15537/1658-3175.5900 · Cited by 10
Adult candidemia at a medical center in northern Taiwan: a retrospective study.
Tsai, C., Wang, C.-C., Kuo, H., Chiang, D.-H., Lin, M.-L., Liu, C.-Y., & Yang, S.-P. (2008) · PubMed · Cited by 10
Echinocandins in invasive candidiasis
Simon, J., Sun, H., Leong, H. N., Barez, M. Y., Huang, P., Talwar, D., Wang, J.-H., Mansor, M. M., Wahjuprajitno, B., Patel, A. K., et al. (2013) · Mycoses · doi:10.1111/myc.12085 · Cited by 11
Metadata
- Authors
- Morrell, M., Fraser, V. J., & Kollef, M. H.
- Affiliations
- Washington University in St. Louis (US)
- Pulmonary and Critical Care Division
- Corresponding author
- Kollef, Marin H.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2005-09
- Volume
- 49
- Issue
- 9
- Pages
- 3640-3645
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC1195428
- OpenAlex
- W2137575148
- Cited by
- 1,286
- References
- 47
- Citations by year
- 2026: 33 · 2025: 33 · 2024: 41 · 2023: 33 · 2022: 53 · 2021: 51 · 2020: 58 · 2019: 63 · 2018: 65 · 2017: 67 · 2016: 71 · 2015: 77 · 2014: 97 · 2013: 75 · 2012: 78
- FWCI
- 27.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- candidemia, fungemia, empirical antifungal therapy, treatment delay, blood culture, in-hospital mortality, APACHE II score, prior antibiotic use, rapid diagnostic tests
- MeSH terms
- Adult, Aged, Aged, 80 and over, Candidiasis, Cross Infection, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Cohort Studies, Logistic Models, Fungemia, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
